|
End-of-day quote
Shenzhen S.E.
2026-11-13
|
5-day change | 1st Jan Change | ||
| 7.820 CNY | -3.58% |
|
-1.51% | -1.51% |
| Market Cap | 4.55B 681M 618M 571M 515M 971M 64.25B 1.01B 6.86B 2.72B 34.32B 2.56B 2.5B 109B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.38B 656M 595M 550M 496M 935M 61.87B 968M 6.61B 2.62B 33.05B 2.46B 2.41B 105B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | -3.58% | ||
| 1 week | -1.51% | ||
| Current month | -3.10% | ||
| 1 month | -5.56% | ||
| 3 months | -10.42% | ||
| 6 months | -12.53% | ||
| Current year | -1.51% |
| 1 week | 7.77 | 8.31 | |
| 1 month | 7.58 | 8.41 | |
| Current year | 7.08 | 11.38 | |
| 1 year | 7.08 | 11.38 | |
| 3 years | 3.58 | 11.98 | |
| 5 years | 3.58 | 11.98 | |
| 10 years | 3.58 | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 2017-12-10 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 2019-07-31 |
Sen Li
COO | Chief Operating Officer | 45 | 2022-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 2019-07-31 |
Ying Yang
CHM | Chairman | 48 | 2019-03-20 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 2019-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.58% | -1.51% | -14.07% | +0.39% | 681M | ||
| +1.26% | +6.61% | +40.79% | +145.27% | 1,286B | ||
| +0.79% | +3.45% | +45.84% | +92.04% | 688B | ||
| +0.20% | +1.28% | +26.97% | +114.41% | 521B | ||
| -0.44% | +3.69% | +41.45% | +70.04% | 386B | ||
| +0.55% | +0.70% | +59.02% | +45.79% | 364B | ||
| -0.12% | +0.74% | +28.39% | +60.32% | 302B | ||
| +0.37% | +0.37% | +3.33% | +38.57% | 287B | ||
| -0.30% | +1.14% | +38.29% | +70.56% | 252B | ||
| +0.08% | +0.71% | +34.44% | +123.99% | 208B | ||
| Average | -0.12% | +1.74% | +30.45% | +76.14% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.69% | +99.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 147M 134M 124M 111M 210M 13.89B 217M 1.48B 588M 7.42B 553M 541M 23.56B | 1.21B 181M 164M 151M 137M 257M 17.03B 266M 1.82B 721M 9.09B 678M 663M 28.87B |
| Net income | 13.65M 2.05M 1.85M 1.71M 1.55M 2.91M 193M 3.02M 20.59M 8.17M 103M 7.67M 7.51M 327M | 92.73M 13.89M 12.59M 11.64M 10.51M 19.8M 1.31B 20.5M 140M 55.47M 700M 52.13M 51.03M 2.22B |
| Net Debt | 189M 28.33M 25.67M 23.74M 21.42M 40.37M 2.67B 41.79M 285M 113M 1.43B 106M 104M 4.53B | -169M -25.29M -22.92M -21.2M -19.13M -36.04M -2.38B -37.31M -255M -101M -1.27B -94.9M -92.89M -4.04B |
Employees
1,188
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | CN¥7.820 | -3.58% | 24,893,888 |
| 26-11-12 | CN¥8.110 | +0.12% | 26,962,899 |
| 26-11-11 | CN¥8.100 | -0.25% | 18,846,117 |
| 26-11-10 | CN¥8.120 | +2.53% | 20,577,578 |
| 26-11-09 | CN¥7.920 | -0.25% | 13,524,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
















